Morning Buzz: Esperion (ESPR), Eli Lilly (LLY), Tesla Motors (TSLA), General Electric (GE)

Esperion Therapeutics, Inc. (ESPR) shares are climbing, up 15.99% to $28.95, in early market trading on Monday following news that Eli Lilly (LLY) would discontinue its development of heart-disease treatment evacetrapib, as it could reduce potential competition for ESPR’s lead candidate ETC-1002. LLY said it expects to record a Q4-charge of $90 million, or $0.05/shr, […] View the full post at: Morning Buzz: Esperion (ESPR), Eli Lilly (LLY), Tesla Motors (TSLA), General Electric (GE) Related posts: General Motors Borrows $4 bln in Additional Federal Aid General Electric’s AAA: The End of an Era Warren Buffett Investing Billions in General Electric